SA
Log In
SCLX
OverviewIntelligenceChart
Next earnings: Jun 3, 2026 · Before open
Signal
Leaning Bullish2↑1↓
Price
1↓
Move↓-1.30%Negative session
Volume
1↑
Volume↑2.7× avgSurge — unusual activity
Technical
1↑
RSI↑RSI 50Momentum positive
PRICE
Prev Close
11.15
Open
11.40
Day Range10.16 – 11.40
10.16
11.40
52W Range3.92 – 34.27
3.92
34.27
23% of range
VOLUME & SIZE
Avg Volume
48.4K
FUNDAMENTALS
P/E Ratio
-0.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev -47% · 60% gross margin
Valuation
FAIR
P/E not available
Health
WEAK
CR 0.1 (low) · FCF $0.31/sh
Lean Bearish
Key MetricsTTM
Market Cap$94.68M
Revenue TTM$30.25M
Net Income TTM-$402.49M
Free Cash Flow$3.42M
Gross Margin59.7%
Net Margin-1330.4%
Operating Margin-900.4%
Return on Equity190.5%
Return on Assets-110.3%
Debt / Equity-0.64
Current Ratio0.08
EPS TTM$-36.48
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong3 concern
51/100
Liquidity
0.08Concern
Leverage
-0.64Strong
Coverage
-23.8xConcern
ROE
190.5%Strong
ROIC
1032.0%Strong
Cash
$5MConcern
ANALYST COVERAGE2 analysts
BUY
Buy
150%
Hold
150%
1 Buy (50%)1 Hold (50%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 4 signals bullish
5/10
Technicals
●
RSI RangeRSI 50 — Bullish momentum
✓
Fundamentals
●
Last EarningsMissed estimates
✗
●
Analyst ConsensusBuy
✓
●
LiquidityCurrent Ratio 0.08 — liquidity risk
✗

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings ReportMay 6, 2026
Tomorrow
DEx-Dividend DateAug 3, 2026
In 90 days
PDividend PaymentSep 1, 2026
In 119 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBEARISH
Technicals →

Trend

▼ DowntrendGolden Cross · 50D leads 200D by 42.7%

-35.2% vs SMA 50 · -7.6% vs SMA 200

Momentum

RSI50.5
Neutral territory
MACD-2.05
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$34.27+211.4%
EMA 50
$16.78+52.5%
EMA 200
$11.91+8.2%
Current
$11.01
52W Low
$3.92-64.4%
52-Week RangeNear 52-week low
$3.9223th %ile$34.27
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 1 analyst
Full estimates →
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$37.6M
$23.4M–$51.7M
—-$32.32—
±50%
Low1
FY2026(current)
$66.0M
$66.0M–$66.0M
▲ +75.7%-$0.89—
—
Low1
FY2027
$189.0M
$189.0M–$189.0M
▲ +186.3%$0.73—
—
Low1
Range confidence:Tight (high)ModerateWide (low)
Earnings HistorySCLX
Last 8Q
-1377.0%avg beat
Beat 2 of 8 quartersMissed 6↑ Estimates rising
-116%
Q2'24
+10%
Q3'24
-3600%
Q1'25
-150%
Q1'25
+46%
Q2'25
-1710%
Q3'25
-4617%
Q4'25
-879%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Insider Activity
SEC Filings →
2 Buys/4 SellsNet Selling
NET BUYERS$4.7M bought · $780K sold · 30d window
Ma Stephen HoiDir
$780K
Apr 17
BUY
Ji HenryDir
$3.9M
Apr 16
BUY
Ji HenryDir
$780K
Apr 17
SELL
Scilex Holding Co10 Percent Own…
$2.8M
Dec 26
SELL
Scilex Holding Co10 Percent Own…
$4.8M
Dec 29
SELL
Scilex Holding Co10 Percent Own…
$5.2M
Dec 30
SELL
Financials

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
CREATIVE FINANCIAL DESIGNS INC /ADV
2K—
2
Versant Capital Management, Inc
761—
3
IFP Advisors, Inc
576▲
4
Activest Wealth Management
302—
5
KLP KAPITALFORVALTNING AS
290—
6
GAMMA Investing LLC
116▼
7
New England Capital Financial Advisors LLC
23—
8
Pacifica Partners Inc.
14—
News & Activity

SCLX News

20 articles · 4h ago

About

No description available.

Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Henry H. JiChief Executive Officer, President & Executive Chairman
Suketu D. DesaiInterim Chief Technical Officer & Senior Vice President
Suresh K. KhemaniSenior Vice President, Chief Commercial Officer & GM of Scilex Pharma

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance